Clinical Trial Update: Sublingual Versus Intranasal Administration of Dexmedetomidine for Sedation of Children Undergoing Dental Treatment [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial comparing sublingual and intranasal dexmedetomidine for sedation in children undergoing dental treatment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders in Children
• Sedation

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Nourhan M.Aly | Conditions: Anti-anxiety Agents, Moderate Sedation | Phase 2, Phase 3 | Status: COMPLETED